Publicação
Enfuvirtide-protoporphyrin IX dual-loaded liposomes: in vitro evidence of synergy against HIV-1 entry into cells
| dc.contributor.author | Figueira, Tiago Nascimento | |
| dc.contributor.author | Domingues, Marco | |
| dc.contributor.author | Illien, Françoise | |
| dc.contributor.author | Cadima Couto, Carla Iris | |
| dc.contributor.author | Todorovski, Toni | |
| dc.contributor.author | Andreu, David | |
| dc.contributor.author | Sagan, Sandrine | |
| dc.contributor.author | Castanho, Miguel A. R. B. | |
| dc.contributor.author | Walrant, Astrid | |
| dc.contributor.author | Veiga, Ana Salomé | |
| dc.date.accessioned | 2023-05-05T15:42:30Z | |
| dc.date.available | 2023-05-05T15:42:30Z | |
| dc.date.issued | 2020 | |
| dc.description | © 2019 American Chemical Society | pt_PT |
| dc.description.abstract | We have developed a nanocarrier consisting of large unilamellar vesicles (LUVs) for combined delivery of two human immunodeficiency virus type 1 (HIV-1) entry inhibitors, enfuvirtide (ENF) and protoporphyrin IX (PPIX). The intrinsic lipophilicity of ENF and PPIX, a fusion inhibitor and an attachment inhibitor, respectively, leads to their spontaneous incorporation into the lipid bilayer of the LUVs nanocarrier. Both entry inhibitors partition significantly toward LUVs composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and a 9:1 mixture of POPC:1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy-(polyethylene glycol)-2000] (DPPE-PEG2000), representative of conventional and immune-evasive drug delivery formulations, respectively. These colocalize in the core of lipid membranes. Dual-loaded nanocarriers are monodispersed and retain the size distribution, thermotropic behavior, and surface charge of the unloaded form. Combination of the two entry inhibitors in the nanocarrier resulted in improved synergy against HIV-1 entry compared to combination in free form, strongly when immuneevasive formulations are used. We propose that the improved action of the entry inhibitors when loaded into the nanocarriers results from their slow release at the site of viral entry. Overall, liposomes remain largely unexplored platforms for combination of viral entry inhibitors, with potential for improvement of current antiretroviral therapy drug safety and application. Our work calls for a reappraisal of the potential of entry inhibitor combinations and delivery for clinical use in antiretroviral therapy. | pt_PT |
| dc.description.sponsorship | This work was supported by European Research Area Networks (ERA-Net) project HIVERA/0002/2013 and Fundação para a Ciência e a Tecnologia (FCT-MCTES) project VIH/SAU/0029/2011. This work has also received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 828774. T.N.F., M.M.D., and I.C. acknowledge individual fellowships SFRH/BD/5283/2013, SFRH/BPD/122779/2016, and SFRH/BPD/65531/2009 funded by FCT-MCTES, respectively. A.S.V. acknowledges funding under the Investigator Programme (IF/00803/2012) from FCT-MCTES. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | ACS Infect. Dis. 2020, 6, 224−236 | pt_PT |
| dc.identifier.doi | 10.1021/acsinfecdis.9b00285 | pt_PT |
| dc.identifier.eissn | 2373-8227 | |
| dc.identifier.uri | http://hdl.handle.net/10451/57373 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | ACS Publications | pt_PT |
| dc.relation | SFRH/BD/5283/2013 | pt_PT |
| dc.relation | ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals | |
| dc.relation | Delivery and targeting fibrinolytic agents to blood clots | |
| dc.relation | MULTI-TARGET HIV ENTRY INHIBITORS DELIVERY BY CATIONIC LIPOSOMES | |
| dc.relation | Towards the development of antimicrobial peptides with antibacterial activity against resistant bacteria and bacterial biofilms | |
| dc.relation.publisherversion | https://pubs.acs.org/journal/aidcbc | pt_PT |
| dc.subject | HIV | pt_PT |
| dc.subject | Entry | pt_PT |
| dc.subject | Inhibitor | pt_PT |
| dc.subject | Liposome | pt_PT |
| dc.subject | Membrane | pt_PT |
| dc.subject | Nanocarrier | pt_PT |
| dc.subject | Delivery | pt_PT |
| dc.title | Enfuvirtide-protoporphyrin IX dual-loaded liposomes: in vitro evidence of synergy against HIV-1 entry into cells | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals | |
| oaire.awardTitle | Delivery and targeting fibrinolytic agents to blood clots | |
| oaire.awardTitle | MULTI-TARGET HIV ENTRY INHIBITORS DELIVERY BY CATIONIC LIPOSOMES | |
| oaire.awardTitle | Towards the development of antimicrobial peptides with antibacterial activity against resistant bacteria and bacterial biofilms | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/HIVERA%2F0002%2F2013/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/VIH%2FSAU%2F0029%2F2011/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/828774/EU | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/OE/SFRH%2FBPD%2F122779%2F2016/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBPD%2F65531%2F2009/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/Investigador FCT/IF%2F00803%2F2012%2FCP0191%2FCT0001/PT | |
| oaire.citation.endPage | 236 | pt_PT |
| oaire.citation.issue | 2 | pt_PT |
| oaire.citation.startPage | 224 | pt_PT |
| oaire.citation.title | ACS Infectious Diseases | pt_PT |
| oaire.citation.volume | 6 | pt_PT |
| oaire.fundingStream | 3599-PPCDT | |
| oaire.fundingStream | 3599-PPCDT | |
| oaire.fundingStream | H2020 | |
| oaire.fundingStream | OE | |
| oaire.fundingStream | FARH | |
| oaire.fundingStream | Investigador FCT | |
| person.familyName | Figueira | |
| person.familyName | Domingues | |
| person.familyName | cadima couto | |
| person.familyName | Castanho | |
| person.familyName | Veiga | |
| person.givenName | Tiago | |
| person.givenName | Marco | |
| person.givenName | carla iris | |
| person.givenName | Miguel | |
| person.givenName | Ana Salome | |
| person.identifier.ciencia-id | E317-92F8-84C6 | |
| person.identifier.orcid | 0000-0002-0813-0745 | |
| person.identifier.orcid | 0000-0003-1502-1421 | |
| person.identifier.orcid | 0000-0001-7398-5857 | |
| person.identifier.orcid | 0000-0001-7891-7562 | |
| person.identifier.orcid | 0000-0002-9892-2243 | |
| person.identifier.scopus-author-id | 56605575600 | |
| person.identifier.scopus-author-id | 56745037100 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100008530 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | European Commission | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | c65d67d4-bb09-45c4-be75-376e1f048665 | |
| relation.isAuthorOfPublication | ce0480de-ac1f-4d55-bf83-19e221bb8768 | |
| relation.isAuthorOfPublication | 231c5019-ce0e-4da1-bda2-1f17c11e7bfa | |
| relation.isAuthorOfPublication | f5e46f85-fabf-450a-9ee2-1c7b59410892 | |
| relation.isAuthorOfPublication | e4303354-5eaa-4d48-8198-de1adc9beb19 | |
| relation.isAuthorOfPublication.latestForDiscovery | e4303354-5eaa-4d48-8198-de1adc9beb19 | |
| relation.isProjectOfPublication | f992a355-2673-47ed-9b17-13d4e6cd4d88 | |
| relation.isProjectOfPublication | 7279b4a8-be45-4de7-835f-fb14b187899f | |
| relation.isProjectOfPublication | d1bca66a-13d0-41bd-bd70-f6039a1fbb33 | |
| relation.isProjectOfPublication | 3ff3136d-1f26-4ec6-b62b-103d20020a86 | |
| relation.isProjectOfPublication | 82e741a8-1495-4f3f-be61-58028c19a625 | |
| relation.isProjectOfPublication | 3692abaa-46d5-489f-b23c-4f37b163ba3c | |
| relation.isProjectOfPublication.latestForDiscovery | 3692abaa-46d5-489f-b23c-4f37b163ba3c |
